BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33340991)

  • 1. Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome.
    Kim JJ; David JM; Wilbon SS; Santos JV; Patel DM; Ahmad A; Mitrofanova A; Liu X; Mallela SK; Ducasa GM; Ge M; Sloan AJ; Al-Ali H; Boulina M; Mendez AJ; Contreras GN; Prunotto M; Sohail A; Fridman R; Miner JH; Merscher S; Fornoni A
    EBioMedicine; 2021 Jan; 63():103162. PubMed ID: 33340991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease.
    Gross O; Girgert R; Beirowski B; Kretzler M; Kang HG; Kruegel J; Miosge N; Busse AC; Segerer S; Vogel WF; Müller GA; Weber M
    Matrix Biol; 2010 Jun; 29(5):346-56. PubMed ID: 20307660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular basement membrane deposition of collagen α1(III) in Alport glomeruli by mesangial filopodia injures podocytes via aberrant signaling through DDR1 and integrin α2β1.
    Madison J; Wilhelm K; Meehan DT; Delimont D; Samuelson G; Cosgrove D
    J Pathol; 2022 Sep; 258(1):26-37. PubMed ID: 35607980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice.
    Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O
    Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome.
    Richter H; Satz AL; Bedoucha M; Buettelmann B; Petersen AC; Harmeier A; Hermosilla R; Hochstrasser R; Burger D; Gsell B; Gasser R; Huber S; Hug MN; Kocer B; Kuhn B; Ritter M; Rudolph MG; Weibel F; Molina-David J; Kim JJ; Santos JV; Stihle M; Georges GJ; Bonfil RD; Fridman R; Uhles S; Moll S; Faul C; Fornoni A; Prunotto M
    ACS Chem Biol; 2019 Jan; 14(1):37-49. PubMed ID: 30452219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Extracellular Matrix Receptor Discoidin Domain Receptor 1 Regulates Collagen Transcription by Translocating to the Nucleus.
    Chiusa M; Hu W; Liao HJ; Su Y; Borza CM; de Caestecker MP; Skrypnyk NI; Fogo AB; Pedchenko V; Li X; Zhang MZ; Hudson BG; Basak T; Vanacore RM; Zent R; Pozzi A
    J Am Soc Nephrol; 2019 Sep; 30(9):1605-1624. PubMed ID: 31383731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discoidin domain receptor 1-deletion ameliorates fibrosis and promotes adipose tissue beiging, brown fat activity, and increased metabolic rate in a mouse model of cardiometabolic disease.
    Lino M; Ngai D; Liu A; Mohabeer A; Harper C; Caruso LL; Schroer SA; Fu F; McKee T; Giacca A; Woo M; Bendeck MP
    Mol Metab; 2020 Sep; 39():101006. PubMed ID: 32360427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model.
    Sannomiya Y; Kaseda S; Kamura M; Yamamoto H; Yamada H; Inamoto M; Kuwazuru J; Niino S; Shuto T; Suico MA; Kai H
    Ren Fail; 2021 Dec; 43(1):510-519. PubMed ID: 33706638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesis.
    Borza CM; Su Y; Tran TL; Yu L; Steyns N; Temple KJ; Skwark MJ; Meiler J; Lindsley CW; Hicks BR; Leitinger B; Zent R; Pozzi A
    Matrix Biol; 2017 Jan; 57-58():258-271. PubMed ID: 27915093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome.
    Widjaja AA; Shekeran SG; Adami E; Ting JGW; Tan J; Viswanathan S; Lim SY; Tan PH; Hübner N; Coffman T; Cook SA
    J Am Soc Nephrol; 2022 Apr; 33(4):718-730. PubMed ID: 35140116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
    Gross O; Beirowski B; Koepke ML; Kuck J; Reiner M; Addicks K; Smyth N; Schulze-Lohoff E; Weber M
    Kidney Int; 2003 Feb; 63(2):438-46. PubMed ID: 12631109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour necrosis factor-α drives Alport glomerulosclerosis in mice by promoting podocyte apoptosis.
    Ryu M; Mulay SR; Miosge N; Gross O; Anders HJ
    J Pathol; 2012 Jan; 226(1):120-31. PubMed ID: 21953121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated expression of integrin α1 in mesangial cells and integrin α3 and vimentin in podocytes of Col4a3-null (Alport) mice.
    Steenhard BM; Vanacore R; Friedman D; Zelenchuk A; Stroganova L; Isom K; St John PL; Hudson BG; Abrahamson DR
    PLoS One; 2012; 7(12):e50745. PubMed ID: 23236390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regime.
    Moll S; Yasui Y; Abed A; Murata T; Shimada H; Maeda A; Fukushima N; Kanamori M; Uhles S; Badi L; Cagarelli T; Formentini I; Drawnel F; Georges G; Bergauer T; Gasser R; Bonfil RD; Fridman R; Richter H; Funk J; Moeller MJ; Chatziantoniou C; Prunotto M
    J Transl Med; 2018 Jun; 16(1):148. PubMed ID: 29859097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome.
    Ge M; Molina J; Kim JJ; Mallela SK; Ahmad A; Varona Santos J; Al-Ali H; Mitrofanova A; Sharma K; Fontanesi F; Merscher S; Fornoni A
    Elife; 2023 May; 12():. PubMed ID: 37129368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDR1 (Discoidin Domain Receptor-1)-RhoA (Ras Homolog Family Member A) Axis Senses Matrix Stiffness to Promote Vascular Calcification.
    Ngai D; Lino M; Rothenberg KE; Simmons CA; Fernandez-Gonzalez R; Bendeck MP
    Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1763-1776. PubMed ID: 32493168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen stimulates discoidin domain receptor 1-mediated migration of smooth muscle cells through Src.
    Lu KK; Trcka D; Bendeck MP
    Cardiovasc Pathol; 2011; 20(2):71-6. PubMed ID: 20093046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic Vascular Calcification Mediated by the Collagen Receptor Discoidin Domain Receptor 1 via the Phosphoinositide 3-Kinase/Akt/Runt-Related Transcription Factor 2 Signaling Axis.
    Lino M; Wan MH; Rocca AS; Ngai D; Shobeiri N; Hou G; Ge C; Franceschi RT; Bendeck MP
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1878-1889. PubMed ID: 29930002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDR1 contributes to kidney inflammation and fibrosis by promoting the phosphorylation of BCR and STAT3.
    Borza CM; Bolas G; Bock F; Zhang X; Akabogu FC; Zhang MZ; de Caestecker M; Yang M; Yang H; Lee E; Gewin L; Fogo AB; McDonald WH; Zent R; Pozzi A
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34941574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptopodin deficiency exacerbates kidney disease in a mouse model of Alport syndrome.
    Ning L; Suleiman HY; Miner JH
    Am J Physiol Renal Physiol; 2021 Jul; 321(1):F12-F25. PubMed ID: 34029143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.